← Back to Search

Consult followed by Engage Model for Hearing Loss (HearCARE Trial)

N/A
Waitlist Available
Led By Catherine Palmer, PhD
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (enrollment), at 5, 10, 15, 20 and 25 months
Awards & highlights

HearCARE Trial Summary

This trial proposes to compare the effectiveness of the two models of care on (a) communication ability, (b) health-related quality of life, and (c) hearing aid use.

Eligible Conditions
  • Age-Related Hearing Loss

HearCARE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (enrollment), at 5, 10, 15, 20 and 25 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (enrollment), at 5, 10, 15, 20 and 25 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Hearing-Specific Health-Related Quality of Life
Satisfaction with Social Participation
Secondary outcome measures
Family Burden
Staff Satisfaction

HearCARE Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Consult ModelExperimental Treatment1 Intervention
The Consult Model (i.e., usual care) is an acute care strategy, relying on a monthly Audiologist visit to the facility.
Group II: HearCARE (Consult+Engage)Active Control2 Interventions
Residents will be exposed to the Consult Model and the Engage Model.

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,719 Previous Clinical Trials
16,341,659 Total Patients Enrolled
Patient-Centered Outcomes Research InstituteOTHER
549 Previous Clinical Trials
29,995,866 Total Patients Enrolled
Catherine Palmer, PhD5.01 ReviewsPrincipal Investigator - University of Pittsburgh
University of Pittsburgh
5Patient Review
Dr. Palmer is extremely knowledgeable and always takes the time to explain things in detail. She's also very supportive and encouraging, which makes me feel confident that I'm in good hands. I'm fortunate to have her as my audiologist!

Media Library

Consult followed by Engage Model Clinical Trial Eligibility Overview. Trial Name: NCT04575051 — N/A
Age-Related Hearing Loss Research Study Groups: Consult Model, HearCARE (Consult+Engage)
Age-Related Hearing Loss Clinical Trial 2023: Consult followed by Engage Model Highlights & Side Effects. Trial Name: NCT04575051 — N/A
Consult followed by Engage Model 2023 Treatment Timeline for Medical Study. Trial Name: NCT04575051 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there a period for new enrolment within this experiment?

"The information hosted on clinicaltrials.gov reveals that this experiment is currently seeking subjects, with the initial post date being June 1st 2021 and last updated April 29th 2022."

Answered by AI

What is the current size of the cohort involved in this clinical trial?

"Affirmative. Records on clinicaltrials.gov verifies that this experiment, which was published initially in June 2021, is presently enlisting volunteers. Approximately 520 patients need to be recruited from 1 trial centre."

Answered by AI
~178 spots leftby Apr 2025